(Q80391873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Antihypertensive effect of irbesartan and predictors of response in obesity-associated hypertension : a prospective, open-label study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

Arya M Sharma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Wilhelm Kirch

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

765-776

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

Obesity-associated hypertension: new insights into mechanisms.

31 December 2019

cites work

1 reference

12 December 2020

Body mass index versus height and weight in relation to blood pressure. Findings for the 10,079 persons in the INTERSALT Study

1 reference

12 December 2020

Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Body mass index and the prevalence of hypertension and dyslipidemia

1 reference

12 December 2020

Irbesartan: an updated review of its use in cardiovascular disorders

1 reference

12 December 2020

Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy

1 reference

12 December 2020

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled

1 reference

12 December 2020

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

12 December 2020

Regression of microalbuminuria in type 2 diabetics after switch to irbesartan treatment : an observational study in 38 016 patients in primary care

1 reference

12 December 2020

A systematic review of the associations between dose regimens and medication compliance

1 reference

12 December 2020

A comparison of observational studies and randomized, controlled trials

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Angiotensin blockade prevents type 2 diabetes by formation of fat cells

1 reference

12 December 2020

The kidney, hypertension, and obesity

1 reference

12 December 2020

Body mass index, waist hip ratio, and waist circumference: which measure to classify obesity?

1 reference

12 December 2020

The spread of the obesity epidemic in the United States, 1991-1998

1 reference

12 December 2020

Obesity as a medical problem

1 reference

12 December 2020

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

1 reference

12 December 2020

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

1 reference

12 December 2020

Obstructive sleep apnea and cardiovascular disease

1 reference

12 December 2020

AT1-receptor antagonism in hypertension: what has been learned with irbesartan?

1 reference

12 December 2020

Differences Between Angiotensin-Converting Enzyme Inhibition and Angiotensin II-AT1 Antagonism on Angiotensin-Mediated Responses in Human Internal Mammary Arteries

1 reference

12 December 2020

Prävalenz und Pharmakotherapie des Diabetes mellitus in der primärärztlichen Versorgung

1 reference

12 December 2020

Predictors of uncontrolled hypertension in ambulatory patients

1 reference

12 December 2020

Patterns of antihypertensive drug utilization in primary care

1 reference

12 December 2020

Preserving cardiac function in the hypertensive patient: why renal parameters hold the key.

1 reference

12 December 2020

Is there a rationale for angiotensin blockade in the management of obesity hypertension?

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Optimizing blood pressure control in the obese patient

1 reference

12 December 2020

Classification of obesity and assessment of obesity-related health risks

1 reference

12 December 2020

The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary care

1 reference

12 December 2020

Obesity and hypertension: epidemiological and clinical issues

1 reference

12 December 2020

A population-based European cohort study of persistence in newly diagnosed hypertensive patients

1 reference

12 December 2020

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

1 reference

12 December 2020

10.2165/00044011-200525120-00003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532722%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference